The landscape of blood sugar treatment is advancing with the arrival of GLP-1 patches . These novel patches offer a likely simpler alternative to injections for individuals dealing with type 2 diabetes . These patches deliver a GLP-1 agonist directly through the dermis , bypassing the need for regular injections and potentially improving patient ad